ISSX is governed by the ISSX Council, a group of member-elected scientific leaders in the field representing the three regions of Asia Pacific, Europe, and North America. The ISSX Council members each serve a term of two years.
 |
Aleksandra Galetin, President
University of Manchester, Manchester, England, United Kingdom Second Term Concludes December 2025 |
|
Mike Zientek, President-Elect Treeline Biosciences, Carlsbad, California, United States First Term Concludes December 2025 |
 |
Mary Paine, Treasurer Washington State University, Spokane, Washington, United States
Second Term Concludes December 2025
|
|
Albert Li, Treasurer-Elect
Retired, Huntsville, Alabama, United States
First Term Concludes December 2025
|
|
|
Yuji Ishii, Council Member
Kyushu University, Koga-City, Fukuoka, Japan
First Term Concludes December 2025
|
| | Barry Jones, Council Member Pharmaron, Rushden, UK First Term Concludes December 2026 |
 |
Valerie Kramlinger, Council Member
Amgen, Nashville, Tennessee, United States
First Term Concludes December 2025 |  | Swati Nagar, Council Member Temple University, Philadelphia, Pennsylvania, United States Second Term Concludes December 2026 | 
| Amin Rostami, Council Member University of Manchester, Manchester, England, United Kingdom First Term Concludes December 2025 |
|
| Hiroshi Yamazaki, Council Member Showa Pharmaceutical University, Tokyo, Japan
Second Term Concludes December 2026
|
|
Andrew Parkinson, Scientific Affairs Committee (SAC) Chair
(Ex Officio to Council)
XPD Consulting, Shawnee Mission, Kansas, United States
First Term Concludes December 2025
|
|
Print Page